Q1 2024 · 13F-HR
Octagon Capital Advisors LPholdings as filed
Filed 2024-05-15 · accession 0001214659-24-009309
$834.4M
Reported value
57
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $165.0M | 19.8% | 2,806,980 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $49.2M | 5.90% | 1,241,300 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $41.4M | 4.96% | 1,380,667 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $38.1M | 4.57% | 2,369,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $35.3M | 4.23% | 1,242,945 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $34.7M | 4.16% | 1,943,836 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $30.9M | 3.71% | 1,140,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $23.3M | 2.79% | 2,060,100 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $22.6M | 2.71% | 1,093,503 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $22.1M | 2.64% | 2,425,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $21.7M | 2.60% | 506,604 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $21.3M | 2.56% | 690,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $20.2M | 2.43% | 2,153,000 | Common | SOLE |
| 46489V104 | ISREUR | PERSPECTIVE THERAPEUTICS INC | $17.5M | 2.10% | 14,718,422 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $15.9M | 1.90% | 405,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $15.9M | 1.90% | 260,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $14.9M | 1.79% | 2,854,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $14.7M | 1.76% | 500,811 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $14.7M | 1.76% | 2,050,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $13.6M | 1.63% | 194,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $11.9M | 1.43% | 403,685 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $11.8M | 1.41% | 200,000 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $10.9M | 1.30% | 620,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $10.8M | 1.30% | 9,187,883 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $9.6M | 1.16% | 408,000 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $9.0M | 1.08% | 3,000,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $8.8M | 1.06% | 273,289 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $8.7M | 1.04% | 3,030,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $8.6M | 1.03% | 340,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $8.3M | 0.99% | 1,501,114 | Common | SOLE |
| 23256X100 | — | CYBIN INC | $7.7M | 0.92% | 18,604,650 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $7.2M | 0.86% | 250,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $7.1M | 0.85% | 550,000 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $6.8M | 0.82% | 315,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $5.5M | 0.66% | 376,117 | Common | SOLE |
| 92731L106 | — | VINCERX PHARMA INC | $5.1M | 0.61% | 1,000,000 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $5.0M | 0.60% | 1,374,870 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $4.8M | 0.58% | 455,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $4.5M | 0.54% | 1,000,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $4.1M | 0.49% | 625,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $3.8M | 0.46% | 520,800 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $3.7M | 0.45% | 2,250,000 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $3.7M | 0.45% | 165,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $3.6M | 0.43% | 360,800 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $3.6M | 0.43% | 1,103,000 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $3.2M | 0.39% | 720,000 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $3.2M | 0.38% | 4,200,000 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $2.7M | 0.32% | 3,800,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $2.6M | 0.31% | 292,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $2.6M | 0.31% | 240,000 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.31% | 250,000 | Common | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $2.3M | 0.28% | 736,000 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $2.3M | 0.27% | 540,000 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $1.8M | 0.22% | 767,799 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $1.4M | 0.16% | 700,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.1M | 0.13% | 176,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $887,120 | 0.11% | 52,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.